Deerfield Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-69,089
Closed -$3.37M 162
2025
Q3
$3.37M Buy
69,089
+65,560
+1,858% +$4.06M 0.05% 81
2025
Q2
$263K Buy
+3,529
New +$234K ﹤0.01% 98
2024
Q3
Sell
-6,036
Closed -$499K 530
2024
Q2
$499K Buy
+6,036
New +$531K 0.01% 264

Other funds holding HAE

Deerfield Management's HAE Position: Q4 2025 in Review

Deerfield Management sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 69,089 shares — an estimated $3.37M sold.

Deerfield Management first reported a position in HAE in Q2 2024 and held it in 3 quarters. The position peaked at $3.37M in Q3 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Deerfield Management reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Deerfield Management sold 69,089 Haemonetics shares in Q4 2025, an estimated $3.37M.
  • Deerfield Management first reported a position in Haemonetics in Q2 2024 and held it in 3 quarters.
  • Deerfield Management's Haemonetics position peaked at $3.37M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Deerfield Management's 13F filing for Q4 2025, filed 17 Feb 2026.